Renaissance Technologies's CAH Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 773,825 shares of Cardinal Health, Inc. (CAH) worth $159.02 M, representing 0.25% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in CAH, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2018, adding 2.18 M shares. Largest reduction occurred in Q1 2025, reducing 1.09 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Cardinal Health (CAH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cardinal Health (CAH) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +81,525 | Add 11.78% | 773,825 | $205.50 |
| Q3 2025 | +33,892 | Add 5.15% | 692,300 | $156.96 |
| Q2 2025 | +34,800 | Add 5.58% | 658,408 | $168.00 |
| Q1 2025 | -1.09 M | Reduce 63.55% | 623,608 | $137.77 |
| Q4 2024 | -116,333 | Reduce 6.37% | 1.71 M | $118.27 |
| Q3 2024 | +143,594 | Add 8.53% | 1.83 M | $110.52 |
| Q2 2024 | +111,137 | Add 7.07% | 1.68 M | $98.32 |
| Q1 2024 | -257,000 | Reduce 14.05% | 1.57 M | $111.90 |
| Q4 2023 | +674,410 | Add 58.40% | 1.83 M | $100.80 |
| Q3 2023 | -50,804 | Reduce 4.21% | 1.15 M | $86.82 |
| Q2 2023 | +735,004 | Add 156.15% | 1.21 M | $0.09 |
| Q1 2023 | -71,700 | Reduce 13.22% | 470,700 | $0.08 |
| Q4 2022 | +542,400 | New Buy | 542,400 | $0.08 |
| Q3 2022 | -182,000 | Sold Out | 0 | $0.00 |
| Q2 2022 | +182,000 | New Buy | 182,000 | $52.27 |
| Q1 2022 | -403,900 | Sold Out | 0 | $0.00 |
| Q4 2021 | +403,900 | New Buy | 403,900 | $51.49 |
| Q3 2021 | -405,000 | Sold Out | 0 | $0.00 |
| Q2 2021 | +228,100 | Add 128.94% | 405,000 | $57.09 |
| Q1 2021 | -516,822 | Reduce 74.50% | 176,900 | $60.75 |
| Q4 2020 | -733,472 | Reduce 51.39% | 693,722 | $53.56 |
| Q3 2020 | +322,300 | Add 29.17% | 1.43 M | $46.95 |
| Q2 2020 | -166,552 | Reduce 13.10% | 1.1 M | $52.19 |
| Q1 2020 | -337,434 | Reduce 20.97% | 1.27 M | $47.94 |
| Q4 2019 | -385,840 | Reduce 19.34% | 1.61 M | $50.58 |
| Q3 2019 | +362,800 | Add 22.23% | 1.99 M | $47.19 |
| Q2 2019 | -411,800 | Reduce 20.15% | 1.63 M | $47.10 |
| Q1 2019 | -112,700 | Reduce 5.23% | 2.04 M | $48.15 |
| Q4 2018 | -379,380 | Reduce 14.96% | 2.16 M | $44.60 |
| Q3 2018 | +2.18 M | Add 611.50% | 2.54 M | $54.00 |
| Q2 2018 | +356,400 | New Buy | 356,400 | $48.83 |
| Q1 2018 | -77,900 | Sold Out | 0 | $0.00 |
| Q4 2017 | +77,900 | New Buy | 77,900 | $61.27 |
| Q4 2016 | -261,600 | Sold Out | 0 | $0.00 |
| Q3 2016 | +135,200 | Add 106.96% | 261,600 | $77.70 |
| Q2 2016 | +59,100 | Add 87.82% | 126,400 | $78.01 |
| Q1 2016 | -529,400 | Reduce 88.72% | 67,300 | $81.95 |
| Q4 2015 | -89,000 | Reduce 12.98% | 596,700 | $89.27 |
| Q3 2015 | +685,700 | New Buy | 685,700 | $76.82 |
| Q3 2014 | -123,000 | Sold Out | 0 | $0.00 |
| Q2 2014 | +123,000 | New Buy | 123,000 | $68.56 |
| Q1 2014 | -44,000 | Sold Out | 0 | $0.00 |
| Q4 2013 | +22,300 | Add 102.76% | 44,000 | $66.82 |
| Q3 2013 | +21,700 | New Buy | 21,700 | $52.17 |
Renaissance Technologies's Cardinal Health Investment FAQs
Renaissance Technologies first purchased Cardinal Health, Inc. (CAH) in Q3 2013, acquiring 21,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Cardinal Health, Inc. (CAH) for 44 quarters since Q3 2013.
Renaissance Technologies's largest addition to Cardinal Health, Inc. (CAH) was in Q3 2018, adding 2,535,800 shares worth $136.93 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 773,825 shares of Cardinal Health, Inc. (CAH), valued at approximately $159.02 M.
As of the Q4 2025 filing, Cardinal Health, Inc. (CAH) represents approximately 0.25% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Cardinal Health, Inc. (CAH) was 2,535,800 shares, as reported at the end of Q3 2018.